Research progress on desensitization of hypersensitivity reaction to iodinated contrast media

Desensitization therapy for iodinated contrast media (ICM) aims to induce drug tolerance in patients with a history of severe allergic reactions to ICM in a short time. Currently, there is no widely accepted consensus on inducing desensitization to avoid severe allergic responses to ICM. The clinically successful cases have shown that prophylactic use of antihistamines and glucocorticoids can increase the desensitization effect; repeatedly desensitizing and gradually increasing the dose can be conducive to establishing better tolerance to ICM. Most desensitization effects, including stress resistance, can endure 24-48 h. The mechanisms of desensitization therapy remain unclear, the initial dose, administration interval and dose gradient are largely based on clinical experiences and the reaction of patients. This article reviews the current research progress on ICM-related allergies, desensitization methods and related mechanisms, as well as the benefits and hazards of desensitization, to provide a reference for desensitization treatment of hypersensitivity to ICM.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:52

Enthalten in:

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences - 52(2023), 4 vom: 25. Aug., Seite 526-530

Sprache:

Englisch

Weiterer Titel:

碘造影剂超敏反应患者脱敏治疗的研究进展

Beteiligte Personen:

Fan, Miao [VerfasserIn]
Zheng, Xiaomeng [VerfasserIn]
Zhu, Suyan [VerfasserIn]

Links:

Volltext

Themen:

Contrast Media
Desensitization therapy
Effective duration
Glucocorticoids
Hypersensitive
Iodinated contrast media
Journal Article
Mechanism
Regimen
Review

Anmerkungen:

Date Completed 31.08.2023

Date Revised 15.11.2023

published: Print

Citation Status MEDLINE

doi:

10.3724/zdxbyxb-2023-0220

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361418906